The drugmaker has recalled six lots of Accuretic tablets; one lot of quinapril and hydrochlorothiazide tablets distributed by Greenstone; and four lots of quinapril HCI/chlorothiazide tablets, also distributed by Greenstone.
“Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines,” Pfizer said in a statement, noting the recall was issued after finding levels above the acceptable daily intake.
“These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”
Pfizer said it is not aware of any adverse events related to the recall to date and that wholesalers and distributors with existing inventory of recalled lots should stop distributing the product immediately.
To view details on the recalled lots, click here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.